Mario R Cornejo-Olivas
Overview
Explore the profile of Mario R Cornejo-Olivas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moura S, Nasciben L, Ramirez A, Coombs L, Rivero J, Van Booven D, et al.
Alzheimers Dement
. 2025 Feb;
21(2):e70031.
PMID: 40008916
Introduction: Genome-wide association studies (GWAS) studies in Alzheimer's disease (AD) demonstrate ancestry-specific loci. Previous studies in the regulatory architecture have only been conducted in Europeans (EUs), thus studies in additional...
2.
Cruz-Gonzalez S, Gu E, Gomez L, Mews M, Vance J, Cuccaro M, et al.
bioRxiv
. 2024 Oct;
PMID: 39464059
Epigenetic clocks that quantify rates of aging from DNA methylation patterns across the genome have emerged as a potential biomarker for risk of age-related diseases, like Alzheimer's disease (AD), and...
3.
Danzi M, Powell E, Rebelo A, Dohrn M, Beijer D, Fazal S, et al.
Exp Neurol
. 2024 Oct;
382:114978.
PMID: 39357594
In the past decade, human genetics research saw an acceleration of disease gene discovery and further dissection of the genetic architectures of many disorders. Much of this progress was enabled...
4.
Weber J, Czisch L, Pereira Sena P, Fath F, Huridou C, Schwarz N, et al.
Acta Neuropathol
. 2024 Aug;
148(1):14.
PMID: 39088078
Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative spinocerebellar ataxia caused by a polyglutamine-coding CAG repeat expansion in the ATXN3 gene. While the CAG length correlates negatively with the age...
5.
Griswold A, Rajabli F, Gu T, Arvizu J, Golightly C, Whitehead P, et al.
medRxiv
. 2024 Apr;
PMID: 38645114
Introduction: Plasma phosphorylated threonine-181 of Tau and amyloid beta are biomarkers for differential diagnosis and preclinical detection of Alzheimer disease (AD). Given differences in AD risk across diverse populations, generalizability...
6.
Leal T, Rao S, French-Kwawu J, Gouveia M, Borda V, Bandres-Ciga S, et al.
Mov Disord
. 2023 Jul;
38(9):1625-1635.
PMID: 37469269
Background: Sex differences in Parkinson's disease (PD) risk are well-known. However, the role of sex chromosomes in the development and progression of PD is still unclear. Objective: The objective of...
7.
Leal T, French-Kwawu J, Gouveia M, Borda V, Inca-Martinez M, Mason E, et al.
medRxiv
. 2023 Feb;
PMID: 36778409
Sex differences in Parkinson Disease (PD) risk are well-known. However, it is still unclear the role of sex chromosomes in the development and progression of PD. We performed the first...
8.
Silva-Paredes G, Urbanos-Garrido R, Inca-Martinez M, Rabinowitz D, Cornejo-Olivas M
BMC Health Serv Res
. 2020 Jan;
19(1):1017.
PMID: 31888613
Background: Huntington's disease (HD) is a devastating and fatal neurodegenerative disorder that leads to progressive disability, and over time to total dependence. The economic impact of HD on patients living...
9.
Cornejo-Olivas M, Inca-Martinez M, Espinoza-Huertas K, Veliz-Otani D, Velit-Salazar M, Marca V, et al.
J Huntingtons Dis
. 2015 Sep;
4(1):99-105.
PMID: 26333261
Background: Late onset cases of Huntington disease (HD), with onset ≥60 years, account for up to 20% of HD cases worldwide. Clinical features include mild motor dysfunction with slow progression...
10.
Cornejo-Olivas M, Torres L, Mata I, Mazzetti P, Rivas D, Cosentino C, et al.
Parkinsonism Relat Disord
. 2015 Mar;
21(5):444-8.
PMID: 25817512
Background: Mutations in PARK2 result in autosomal recessive young onset Parkinson's disease (YOPD). Although there have been a number of reports on the clinical characteristics of PARK2-related PD, there is...